Agents blocking the nuclear factor-kappaB pathway are effective inhibitors of endometriosis in an in vivo

Reinaldo González-Ramos1, Anne Van Langendonckt, Sylvie Defrère

  • 1Department of Gynecology, Université Catholique de Louvain, Brussels, Belgium.

Abstract

Insights

Inhibition of nuclear factor-kappa B (NF-kappaB) in an animal model reduced endometriosis lesion development by decreasing inflammation and cell growth while increasing cell death.

Area of Science:

  • Reproductive Biology
  • Molecular Biology
  • Pathology

Background:

  • In vitro studies implicate nuclear factor-kappa B (NF-kappaB) in inflammatory signaling in endometriosis.
  • The role of NF-kappaB in the in vivo development of endometriotic lesions requires investigation.

Purpose of the Study:

  • To investigate the involvement of NF-kappaB in the initial development of endometriotic lesions in vivo.
  • To determine the effect of NF-kappaB inhibition on lesion growth and associated molecular processes.

Main Methods:

  • Endometriosis was induced in nude mice using fluorescent-labeled menstrual endometrium.
  • Mice received NF-kappaB inhibitors (BAY 11-7085, SN-50) or vehicle control.
  • Lesion development, NF-kappaB activation, ICAM-1 expression, proliferation, and apoptosis were quantified.

Main Results:

  • NF-kappaB inhibitors significantly reduced endometriotic lesion development.
  • Inhibitors decreased NF-kappaB activation and intercellular adhesion molecule (ICAM)-1 expression.
  • Cell proliferation was reduced, while apoptosis was significantly increased in endometriotic lesions.

Conclusions:

  • The NF-kappaB pathway is crucial for endometriotic lesion development in vivo.
  • NF-kappaB inhibition diminishes endometriosis progression by modulating inflammation, proliferation, and apoptosis.
  • Targeting NF-kappaB presents a potential therapeutic strategy for endometriosis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...